Joint labelling for veterinary medicines for use in the UK a

Joint labelling for veterinary medicines for use in the UK and Ireland


Joint labelling for veterinary medicines for use in the UK and Ireland
Guidance for the veterinary pharmaceutical industry on how to apply for and maintain a joint-label for use on veterinary medicines placed on the market in the UK and Ireland.
From:
Eligible Marketing Authorisations and criteria
Joint-labelling allows for a single label/leaflet that has been agreed by the VMD, on behalf of the UK, and the Health Products Regulatory Authority (
HPRA), on behalf of Ireland, for use on veterinary medicines marketed in their countries.
Joint labelling could be achieved between GB and IE, NI and IE or all three - GB, IE and NI. You should also refer to the

Related Keywords

Ireland , United Kingdom , , Health Products Regulatory Authority , Company Response , Eligible Marketing Authorisations , Marketing Authorisations , Marketing Authorisation Holder , Product Characteristics , Centrally Authorised Products , Product Literature , ஐயர்ல்யாஂட் , ஒன்றுபட்டது கிஂக்டம் , ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் , நிறுவனம் பதில் , ப்ராடக்ட் பண்புகள் , மையமாக அங்கீகாரம் பெற்றது ப்ராடக்ட்ஸ் , ப்ராடக்ட் இலக்கியம் ,

© 2025 Vimarsana